首页> 外文期刊>Mediators of inflammation >Serum IL-1β, sIL-2R, IL-6, IL-8 and TNF-α in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatment
【24h】

Serum IL-1β, sIL-2R, IL-6, IL-8 and TNF-α in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatment

机译:精神分裂症患者血清IL-1β,sIL-2R,IL-6,IL-8和TNF-α与利培酮治疗的症状和反应性的关系

获取原文
           

摘要

Activation of the inflammatory response system and varied levels of cytokines in acute schizophrenia have been suggested by recent studies. Psychopharmacologic agents can differentially effect cytokine production, which suggests that therapeutic function of neuroleptics may involve immunomodulation.The present study was carried out to examine: (i) serum concentrations of interleukin (IL)-1β , soluble interleukin-2 receptor (sIL-2R), IL-6, IL-8 and tumour necrosis factor (TNF)- α in schizophrenic patients; (ii) their relation with psychopathological assessment; and (iii) the relation of the initial cytokine levels with responsiveness to risperidone therapy.Thirty-four drug-free schizophrenic patients with acute exacerbation and 23 age- and gender-matched healthy controls were recruited for this study. Psychopathological assessments at admission and throughout risperidone treatment for 60 days were recorded. Serum cytokine concentrations were determined with chemilumunescence assays.According to our results, serum IL-1β , sIL-2R, IL-6, IL-8 and TNF-α concentrations adjusted for age, gender, body mass index and smoking were no different in patients with schizophrenia and controls and among subtypes of schizophrenia. However, the initial TNF-α concentrations had a significant effect on Brief Psychiatric Rating Scale and Scale Assessment of Positive Symptoms scores. The initial cytokine concentrations of the patients responsive to risperidone were not significantly different from those of non-responsive patients.The present study demonstrates that plasma levels of IL-1β , sIL-2R, IL-6, IL-8 and TNF-α adjusted for confounding factors are not altered in drug-free schizophrenic patients at acute exacerbation. We suggest that, if cytokine production is altered in schizophrenia, these alterations may not be detectable in systemic circulation. According to our results, the therapeutic effect of risperidone is not related to basal levels of the aforementioned cytokines. However, serum TNF-α may contribute to symptomatology in schizophrenia.
机译:最近的研究表明,急性精神分裂症中炎症反应系统的激活和细胞因子水平的变化。心理药物可以不同程度地影响细胞因子的产生,这表明止痛药的治疗功能可能涉及免疫调节。本研究旨在检查:(i)血清白介素(IL)-1β,可溶性白介素2受体(sIL-2R)的浓度),精神分裂症患者的IL-6,IL-8和肿瘤坏死因子(TNF)-α; (ii)它们与心理病理评估的关系; (iii)初始细胞因子水平与利培酮治疗反应的关系。本研究招募了34例急性加重的无药物精神分裂症患者和23例年龄和性别相匹配的健康对照。记录入院时和整个利培酮治疗60天内的心理病理学评估。根据化学发光法测定血清细胞因子浓度。根据我们的结果,经年龄,性别,体重指数和吸烟调整后的血清IL-1β,sIL-2R,IL-6,IL-8和TNF-α浓度无差异。精神分裂症和对照以及精神分裂症亚型的患者。但是,最初的TNF-α浓度对简短的精神病学评定量表和阳性症状量表评估有显着影响。对利培酮有反应的患者的初始细胞因子浓度与无反应的患者无明显差异。本研究表明,血浆中的IL-1β,sIL-2R,IL-6,IL-8和TNF-α水平可以调节无药物的精神分裂症患者急性加重时混杂因素的改变没有改变。我们建议,如果精神分裂症中细胞因子的产生发生改变,这些改变在全身循环中可能无法检测到。根据我们的结果,利培酮的治疗作用与上述细胞因子的基础水平无关。然而,血清TNF-α可能有助于精神分裂症的症状。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号